Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Hosp Infect ; 150: 51-60, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38782058

RESUMEN

The terms 'resistance' and 'tolerance' are well defined in the context of antibiotic research. However, in the field of disinfection, these terms are often used synonymously, which creates ambiguity and can lead to misunderstandings and misconceptions. In addition, this inconsistency in terminology makes it difficult to assess the risk of a disinfectant resistance. This general review aims to discuss existing definitions of the terms 'adaptation', 'susceptibility', 'tolerance', 'persistence' and 'resistance' in the light of disinfectants. The most ambiguity is found between tolerance and resistance. Whereas the former describes the not necessarily heritable survival of transient exposure to usually lethal concentrations, resistance is the strictly heritable ability to survive otherwise lethal concentrations of an antimicrobial agent, regardless of exposure time. A simple transfer of experience from antibiotic research is not recommended when assessing the risk of resistance to disinfectants, as there are important differences between antibiotics and disinfectants, although both are antimicrobials: (i) disinfectants are usually applied at concentrations that exceed the minimum inhibitory concentration by orders of magnitude, (ii) the exposure times of disinfectants are in the range of seconds, minutes, or a few hours, (iii) the mode of action of disinfectants is less specific, and (iv) disinfectants often contain more than one active agent with additive or synergistic effects. It is important to recognize that disinfectants, like other antimicrobial agents such as antibiotics, have a dualistic nature and should be used correctly and with caution.


Asunto(s)
Desinfectantes , Desinfección , Terminología como Asunto , Desinfección/métodos , Desinfectantes/farmacología , Humanos , Bacterias/efectos de los fármacos , Bacterias/clasificación , Tolerancia a Medicamentos , Farmacorresistencia Bacteriana , Antibacterianos/farmacología
2.
J Hosp Infect ; 128: 39-46, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35835285

RESUMEN

BACKGROUND: Hand hygiene at critical time-points (as established by the World Health Organization's model 'Five Moments for Hand Hygiene') remains the leading measure for minimizing the risk of healthcare-associated infections. While many interventions have been tested to improve hand hygiene compliance (HHC) of healthcare workers (HCWs), little is known about the relationship between HHC and empathy of HCWs. AIM: To investigate the relationship between moment-specific HHC rates and empathy of HCWs at both individual and ward levels. METHODS: HHC data were collected via observation and self-report, and empathy levels were measured using an established questionnaire. The survey was conducted on 38 wards of three tertiary care hospitals in Germany. Observation data were obtained via in-house observations conducted ≤8 months before or after the survey. FINDINGS: Evidence for the expected correlation between empathy of HCWs and moment-specific HHC was found for both observed HHC (Moment 1: r=0.483, P=0.031; Moment 2: r=588, P=0.006) and self-reported HHC (Moment 1: r=0.093, P=0.092; Moment 2: r=0.145, P=0.008). In analyses of variance, the critical interaction effect between empathy (i.e. lower vs higher empathy) and designated time-point of hand hygiene (i.e. before vs after reference task) was also significant. CONCLUSION: Empathy of HCWs should be considered as an important factor in explaining differences between moment-specific HHC rates. In consequence, empathy comes into focus not only as a crucial factor for high-quality patient care, but also as an important contributor to improving HHC.


Asunto(s)
Infección Hospitalaria , Higiene de las Manos , Infección Hospitalaria/prevención & control , Empatía , Adhesión a Directriz , Desinfección de las Manos , Personal de Salud , Humanos , Autoinforme
3.
J Virol Methods ; 158(1-2): 123-9, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19428580

RESUMEN

A bovine in vitro organ culture (BIVOC) system was evaluated as a model to study host and pathogen events during the course of bovine herpesvirus-1 infection. Upper respiratory tract epithelium, from slaughtered animals, was cultured in an air-liquid interface system and integrity, viability, and TNF-alpha gene expression of tissue explants were monitored over 72h in the presence or absence of infection by bovine herpesvirus type 1 (BHV-1). Uninfected explants maintained viability and integrity over the 72h time course although histological signs of degeneration were first visible from 24h of culture. Explants were productively infected with BHV-1 and typical, dose dependent, cytopathic changes were observed in response to infection. Regulation of TNF-alpha gene expression in uninfected explants varied over time and was region-specific but there was significant down-regulation of TNF-alpha gene expression at 2h post-infection when compared to uninfected controls at the same time point. Taking caveats into consideration the BIVOC system shows promise as a tool for analysis of immediate or early events in host-pathogen interaction.


Asunto(s)
Infecciones por Herpesviridae/patología , Infecciones por Herpesviridae/virología , Herpesvirus Bovino 1/crecimiento & desarrollo , Mucosa Respiratoria/patología , Mucosa Respiratoria/virología , Animales , Bovinos , Supervivencia Celular , Perfilación de la Expresión Génica , Técnicas de Cultivo de Órganos , Factor de Necrosis Tumoral alfa/biosíntesis
4.
Vaccine ; 27(2): 260-9, 2009 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-18984025

RESUMEN

To determine whether systemic immunization with plasmid DNA and virus vector against visna/maedi virus (VMV) would induce protective immune responses, sheep were immunized with VMV gag and/or env sequences using particle-mediated epidermal bombardment and injection of recombinant modified vaccinia Ankara. The results showed that immunization induced both humoral and cell-mediated responses prior to and after virus challenge. The vaccination protocol did not prevent infection, but immunization with the gag gene or a combination of gag and env genes resulted in significantly reduced provirus loads in blood and mediastinal lymph node, respectively. Provirus loads in lung and draining lymph node were unaffected, but p25 expression was undetectable in lungs of animals immunized with a combination of gag and env genes. Analysis of target tissues for lesions at post-mortem showed that immunization with the env gene caused a significant increase in lesion score, while the gag gene or a combination of gag and env genes had no effect. Inclusion of the ovine interferon-gamma gene in the initial priming mixture had minimal effect on immune responses, provirus load, or lesion development, although it resulted in a decreased p25 expression in the lung. The results thus show that systemic immunization with gag or a combination of gag and env genes reduces provirus load in blood and lymphoid tissue, respectively whereas env immunization has no effect on provirus load but increased lesion development.


Asunto(s)
Biolística , Genes env/genética , Genes gag/genética , Neumonía Intersticial Progresiva de los Ovinos/prevención & control , Vacunas de ADN , Virus Vaccinia/genética , Animales , Anticuerpos Antivirales/sangre , Epidermis/virología , Femenino , Genes env/inmunología , Genes gag/inmunología , Inmunización , Masculino , Neumonía Intersticial Progresiva de los Ovinos/virología , Provirus/aislamiento & purificación , Ovinos , Linfocitos T/inmunología , Vacunas de ADN/administración & dosificación , Vacunas de ADN/genética , Vacunas de ADN/inmunología , Virus Vaccinia/inmunología , Vacunas Virales/administración & dosificación , Vacunas Virales/genética , Vacunas Virales/inmunología , Virión/genética , Virión/inmunología , Virus Visna-Maedi
5.
Vaccine ; 26(35): 4494-505, 2008 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-18606204

RESUMEN

Sheep were immunized against Visna/Maedi virus (VMV) gag and/or env genes via the nasopharynx-associated lymphoid tissue (NALT) and lung using polyethylenimine (PEI)-DNA complexes and modified vaccinia Ankara, and challenged with live virus via the lung. env immunization enhanced humoral responses prior to but not after VMV challenge. Systemic T cell proliferative and cytotoxic responses were generally low, with the responses following single gag gene immunization being significantly depressed after challenge. A transient reduction in provirus load in the blood early after challenge was observed following env immunization, whilst the gag gene either alone or in combination with env resulted in significantly elevated provirus loads in lung. However, despite this, a significant reduction in lesion score was observed in animals immunized with the single gag gene at post-mortem. Inclusion of IFN-gamma in the immunization mixture in general had no significant effects. The results thus showed that protective effects against VMV-induced lesions can be induced following respiratory immunization with the single gag gene, though this was accompanied by an increased pulmonary provirus load.


Asunto(s)
Productos del Gen env/inmunología , Productos del Gen pol/inmunología , Neumonía Intersticial Progresiva de los Ovinos/prevención & control , Vacunas de ADN/inmunología , Vacunas Virales/inmunología , Virus Visna-Maedi/inmunología , Animales , Anticuerpos Antivirales/sangre , Proliferación Celular , Pruebas Inmunológicas de Citotoxicidad , Femenino , Productos del Gen env/genética , Productos del Gen pol/genética , Vectores Genéticos , Leucocitos Mononucleares/inmunología , Pulmón/inmunología , Pulmón/patología , Pulmón/virología , Masculino , Nasofaringe/inmunología , Provirus/aislamiento & purificación , Índice de Severidad de la Enfermedad , Ovinos , Linfocitos T Citotóxicos/inmunología , Vacunas de ADN/administración & dosificación , Virus Vaccinia/genética , Carga Viral , Vacunas Virales/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...